Potassium%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an essential electrolyte used to treat and prevent hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment of hypokalemia. * Prevention of hypokalemia, particularly in patients receiving diuretics or corticosteroids. ## Adult Dosing * **Oral Replacement:** * **Mild Hypokalemia (3.0-3.9 mEq/L):** 20-40 mEq per day, divided into 1-2 doses. * **Moderate Hypokalemia (2.5-2.9 mEq/L):** 40-60 mEq per day, divided into 2-3 doses. * **Severe Hypokalemia (<2.5 mEq/L):** Requires careful IV administration and close monitoring. Oral doses can range up to 80-100 mEq per day in divided doses, but often requires IV therapy for rapid correction. * **Maximum oral dose:** Generally limited to 40 mEq per dose to minimize GI upset and risk of hyperkalemia. Total daily dose should not exceed 100-120 mEq without specific indication and close monitoring. * **Intravenous (IV) Replacement:** * Administer **only** in patients with significant hypokalemia or inability to take oral medications. * **General guidelines:** 10-20 mEq per hour. * **Maximum infusion rate:** Typically **10-20 mEq/hour** (up to 40 mEq/hour in life-threatening situations with continuous cardiac monitoring and in an ICU setting). * **Maximum concentration:** Usually **40 mEq/L** in peripheral IV lines to avoid phlebitis. Higher concentrations (up to 80 mEq/L) may be used in central lines with continuous cardiac monitoring. * Dosing depends heavily on serum potassium level, clinical status, and ECG findings. Local protocols are essential. ## Pediatric Dosing * Dosing is based on age and severity of hypokalemia. * **Oral Replacement:** Typical maintenance: 1-2 mEq/kg/day divided into 1-2 doses, not to exceed adult maximums. * **Intravenous (IV) Replacement:** * **General guidelines:** 0.3-1 mEq/kg per dose, infused over 1-3 hours. * **Maximum daily dose:** Typically 100 mEq or 4 mEq/kg/day, whichever is less. * **Maximum infusion rate:** Generally **0.5-1 mEq/kg/hour**, but may be increased to 2 mEq/kg/hour in severe, symptomatic hypokalemia with continuous cardiac monitoring in an ICU. * **Maximum concentration:** Typically **40 mEq/L** in peripheral IV lines. * Precise dosing and administration require careful calculation and close monitoring. ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Reduce dose and monitor potassium closely. Risk of hyperkalemia is significantly increased. In severe renal impairment, potassium supplementation may be contraindicated. ## Contraindications * Hyperkalemia (serum potassium > 5.0 mEq/L). * Conditions leading to elevated potassium levels (e.g., severe renal impairment, untreated Addison's disease, acute dehydration, extensive tissue injury). * Known hypersensitivity to potassium chloride. ## Adverse Effects * **Common:** Nausea, vomiting, diarrhea, abdominal pain (especially with oral formulations). * **Serious:** Hyperkalemia (symptoms include muscle weakness, fatigue, paresthesias, arrhythmias, cardiac arrest), ECG changes (peaked T waves, flattened P waves, prolonged QRS and QT intervals), intestinal obstruction or perforation (rare, with oral slow-release products or undiluted liquid). * Phlebitis or extravasation (with IV administration). ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE inhibitors and ARBs:** Increased risk of hyperkalemia. * **NSAIDs:** May reduce potassium excretion, increasing risk of hyperkalemia. * **Heparin:** May interfere with potassium excretion, increasing risk of hyperkalemia. * **Digoxin:** Hypokalemia increases digoxin toxicity. Hyperkalemia reduces digoxin effect. ## Monitoring * Serum potassium levels (frequency depends on route, dose, severity of hypokalemia, and renal function). * Renal function (BUN, creatinine). * ECG (especially with IV administration or in patients with cardiac history). * Signs and symptoms of hyperkalemia and hypokalemia. ## Clinical Pearls * Oral potassium chloride can be irritating to the GI tract. Administer with food or fluids to minimize upset. * Slow-release oral formulations are associated with a higher risk of GI ulceration and obstruction and are generally less preferred than liquid or standard tablet formulations. * IV potassium chloride is a vesicant and must be administered with caution and appropriate dilution/concentration. * Always verify serum potassium levels before initiating or adjusting potassium therapy. * Hypokalemia can be exacerbated by magnesium deficiency; consider magnesium repletion if indicated. *** **Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and institutional protocols before administering any medication.